CRISPR And Cas Genes Market (By Product: By Product, By Services; By Application: Biomedical, Agricultural; By End-use: Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, Contract Research Organizations (CROs)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Aug 2021 | No. of Pages : 200 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global CRISPR And Cas Genes Market, By Product & service

7.1.  CRISPR And Cas Genes Market, by Product & service, 2021-2030

7.1.1.    By Product

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    By Service

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global CRISPR And Cas Genes Market, By Application

8.1.  CRISPR And Cas Genes Market, by Application, 2021-2030

8.1.1.    Biomedical

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Agricultural

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global CRISPR And Cas Genes Market, By End User

9.1.  CRISPR And Cas Genes Market, by End User, 2021-2030

9.1.1.    Biotechnology & Pharmaceutical Companies

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Academics & Government Research Institutes

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Contract Research Organizations (CROs)

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global CRISPR And Cas Genes Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product & service (2016-2030)

10.1.2.  Market Revenue and Forecast, by Application (2016-2030)

10.1.3.  Market Revenue and Forecast, by End User (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product & service (2016-2030)

10.2.2.  Market Revenue and Forecast, by Application (2016-2030)

10.2.3.  Market Revenue and Forecast, by End User (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product & service (2016-2030)

10.3.2.  Market Revenue and Forecast, by Application (2016-2030)

10.3.3.  Market Revenue and Forecast, by End User (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product & service (2016-2030)

10.4.2.  Market Revenue and Forecast, by Application (2016-2030)

10.4.3.  Market Revenue and Forecast, by End User (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product & service (2016-2030)

10.5.2.  Market Revenue and Forecast, by Application (2016-2030)

10.5.3.  Market Revenue and Forecast, by End User (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product & service (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2016-2030)

Chapter 11.  Company Profiles

11.1.              AstraZeneca plc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Addgene

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Caribou Biosciences, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Cellectis, CRISPR Therapeutics

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Editas Medicine, Inc.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              eGenesis

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              F. Hoffmann-La Roche Ltd.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Horizon Discovery Group plc

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              GenScript

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Danaher Corporation

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           Intellia Therapeutics, Inc.

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

11.12.           Lonza

11.12.1.               Company Overview

11.12.2.               Product Offerings

11.12.3.               Financial Performance

11.12.4.               Recent Initiatives

11.13.           Merck KGaA

11.13.1.               Company Overview

11.13.2.               Product Offerings

11.13.3.               Financial Performance

11.13.4.               Recent Initiatives

11.14.           Intellia Therapeutics, Inc.

11.14.1.               Company Overview

11.14.2.               Product Offerings

11.14.3.               Financial Performance

11.14.4.               Recent Initiatives

11.15.           Takara Bio Inc.

11.15.1.               Company Overview

11.15.2.               Product Offerings

11.15.3.               Financial Performance

11.15.4.               Recent Initiatives

11.16.           Thermo Fisher Scientific, Inc.

11.16.1.               Company Overview

11.16.2.               Product Offerings

11.16.3.               Financial Performance

11.16.4.               Recent Initiatives

11.17.           Synthego

11.17.1.               Company Overview

11.17.2.               Product Offerings

11.17.3.               Financial Performance

11.17.4.               Recent Initiatives

11.18.           Mammoth Biosciences

11.18.1.               Company Overview

11.18.2.               Product Offerings

11.18.3.               Financial Performance

11.18.4.               Recent Initiatives

11.19.           Inscripta, Inc.

11.19.1.               Company Overview

11.19.2.               Product Offerings

11.19.3.               Financial Performance

11.19.4.               Recent Initiatives

11.20.           Cibus

11.20.1.               Company Overview

11.20.2.               Product Offerings

11.20.3.               Financial Performance

11.20.4.               Recent Initiatives

11.21.           Beam Therapeutics

11.21.1.               Company Overview

11.21.2.               Product Offerings

11.21.3.               Financial Performance

11.21.4.               Recent Initiatives

11.22.           PLANTeDIT

11.22.1.               Company Overview

11.22.2.               Product Offerings

11.22.3.               Financial Performance

11.22.4.               Recent Initiatives

11.23.           Vertex Pharmaceuticals Incorporated

11.23.1.               Company Overview

11.23.2.               Product Offerings

11.23.3.               Financial Performance

11.23.4.               Recent Initiatives

11.24.           Hera BioLabs

11.24.1.               Company Overview

11.24.2.               Product Offerings

11.24.3.               Financial Performance

11.24.4.               Recent Initiatives

11.25.           OriGene Technologies, Inc.

11.25.1.               Company Overview

11.25.2.               Product Offerings

11.25.3.               Financial Performance

11.25.4.               Recent Initiatives

11.26.           Recombinetics, Inc.

11.26.1.               Company Overview

11.26.2.               Product Offerings

11.26.3.               Financial Performance

11.26.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Healthcare Testing, Inspection, And Certification Outsourcing Market (By Services: Testing, Inspection, Certification; By Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Pupillometer Market (By Mobility: Table-top, Hand-held; By Type: Video, Digital; By End-use: Hospitals, Eye Clinics; By Application: Ophthalmology, Oncology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    North America And Europe Preclinical Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Cell Banking Outsourcing Market (By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking; By Cell Type; By Phase) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Biologics Contract Development Market (By Source: Mammalian, Microbial; By Product Service Type; By Indication: Oncology, Immunological Disorders) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...